Access the full text.
Sign up today, get DeepDyve free for 14 days.
Björn Schwanhäusser, Dorothea Busse, Na Li, G. Dittmar, J. Schuchhardt, J. Wolf, Wei Chen, M. Selbach (2011)
Global quantification of mammalian gene expression controlNature, 473
N. Tešić, M. Čemažar (2013)
In Vitro Targeted Gene Electrotransfer to Endothelial Cells with Plasmid DNA Containing Human Endothelin-1 PromoterThe Journal of Membrane Biology, 246
M. Čemažar, Ian Wilson, G. Dachs, G. Tozer, G. Serša (2004)
Direct visualization of electroporation-assisted in vivo gene delivery to tumors using intravital microscopy – spatial and time dependent distributionBMC Cancer, 4
A. Kung (2007)
Practices and pitfalls of mouse cancer models in drug discovery.Advances in cancer research, 96
M. Bošnjak, Beatriz Lorente, Z. Pogacar, Vesna Makovsek, M. Čemažar (2014)
Different Incubation Times of Cells After Gene Electrotransfer in Fetal Bovine Serum Affect Cell Viability, but Not Transfection EfficiencyThe Journal of Membrane Biology, 247
J. Cutrera, M. Torrero, K. Shiomitsu, N. Mauldin, Shulin Li (2008)
Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.Methods in molecular biology, 423
Darja Pavlin, M. Čemažar, A. Cör, G. Serša, A. Pogačnik, N. Tozon (2010)
Electrogene therapy with interleukin-12 in canine mast cell tumorsRadiology and Oncology, 45
A. Daud, Noweeda Mirza, Brianna Lenox, S. Andrews, P. Urbas, Gui-xin Gao, J. Lee, V. Sondak, A. Riker, R. Deconti, D. Gabrilovich (2008)
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 19
M. Čemažar, G. Serša, Darja Pavlin, N. Tozon (2011)
Intramuscular IL-12 Electrogene Therapy for Treatment of Spontaneous Canine Tumors
Iben Spanggaard, M. Snoj, A. Cavalcanti, C. Bouquet, G. Serša, C. Robert, M. Čemažar, E. Dam, B. Vasseur, P. Attali, L. Mir, J. Gehl (2013)
Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study.Human gene therapy. Clinical development, 24 3
Kaori Inoue, E. Ohashi, T. Kadosawa, Sung-hyeok Hong, S. Matsunaga, M. Mochizuki, R. Nishimura, N. Sasaki (2004)
Establishment and characterization of four canine melanoma cell lines.The Journal of veterinary medical science, 66 11
Lenita Santos, S. Barrouin-Melo, Yungfu Chang, J. Olsen, S. McDonough, F. Quimby, W. Santos, L. Pontes-de-carvalho, G. Oliveira (2004)
Recombinant single-chain canine interleukin 12 induces interferon gamma mRNA expression in peripheral blood mononuclear cells of dogs with visceral leishmaniasis.Veterinary immunology and immunopathology, 98 1-2
Huichen Guo, Rongzeng Hao, Yanquan Wei, De-hui Sun, Shiqi Sun, Zhencang Zhang (2012)
Optimization of Electrotransfection Conditions of Mammalian Cells with Different Biological FeaturesThe Journal of Membrane Biology, 245
C. Vogel, E. Marcotte (2012)
Insights into the regulation of protein abundance from proteomic and transcriptomic analysesNature Reviews Genetics, 13
E. Amsler, A. Soria (2017)
[Hypersensitivity reactions to beta-lactam antibiotics].La Revue de medecine interne, 38 11
P. Oliveira, Juergen Mairhofer (2013)
Marker-free plasmids for biotechnological applications - implications and perspectives.Trends in biotechnology, 31 9
M. Rols, J. Teissié (1998)
Electropermeabilization of mammalian cells to macromolecules: control by pulse duration.Biophysical journal, 75 3
C. Bloquel, E. Fabre, M. Bureau, D. Scherman (2004)
Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applicationsThe Journal of Gene Medicine, 6
SD Reed, A Fulmer, J Buckholz, B Zhang, J Cutrera, K Shiomitsu, S Li (2010)
Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs (Retraction of vol 17, pg 571, 2010)Cancer Gene Ther, 17
G. Vandermeulen, C. Marie, D. Scherman, V. Préat (2011)
New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.Molecular therapy : the journal of the American Society of Gene Therapy, 19 11
A. Daud, R. Deconti, S. Andrews, P. Urbas, A. Riker, V. Sondak, P. Munster, D. Sullivan, K. Ugen, J. Messina, R. Heller (2008)
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 36
C. Delteil, J. Teissié, M. Rols (2000)
Effect of serum on in vitro electrically mediated gene delivery and expression in mammalian cells.Biochimica et biophysica acta, 1467 2
D. Scelsi, N. Mevio, G. Bertino, A. Occhini, V. Brazzelli, P. Morbini, M. Benazzo (2013)
Electrochemotherapy as a new therapeutic strategy in advanced Merkel cell carcinoma of head and neck regionRadiology and Oncology, 47
S. Reed, A. Fulmer, Julia Buckholz, Boyu Zhang, J. Cutrera, Kiejiro Shiomitsu, Shulin Li (2010)
Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogsCancer Gene Therapy, 17
Marc Gillard, É. Cadieu, Clotilde Brito, J. Abadie, B. Vergier, P. Devauchelle, Frédérique Degorce, S. Dréano, A. Primot, L. Dorso, M. Lagadic, F. Galibert, B. Hédan, M. Galibert, C. André (2014)
Naturally occurring melanomas in dogs as models for non‐UV pathways of human melanomasPigment Cell & Melanoma Research, 27
M. Büttner, G. Belke-Louis, H. Rziha, C. McInnes, O. Kaaden (1998)
Detection, cDNA cloning and sequencing of canine interleukin 12.Cytokine, 10 4
Michael Atkins, Michael Robertson, M. Gordon, M. Lotze, Michelle DeCoste, Jon Dubois, J. Ritz, Alan Sandler, H. Edington, Pamela Garzone, J. Mier, C. Canning, L. Battiato, Hideaki Tahara, M. Sherman (1997)
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.Clinical cancer research : an official journal of the American Association for Cancer Research, 3 3
G. Ranieri, C. Gadaleta, R. Patruno, N. Zizzo, M. Daidone, Mats Hansson, A. Paradiso, Domenico Ribatti (2013)
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies.Critical reviews in oncology/hematology, 88 1
B. Mali, T. Jarm, M. Snoj, G. Sersa, Damijan Miklavcic (2013)
Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 39 1
F. Shebl, L. Pinto, A. García-Piñeres, R. Lempicki, Marcus Williams, Clayton Harro, A. Hildesheim (2010)
Comparison of mRNA and Protein Measures of Cytokines following Vaccination with Human Papillomavirus-16 L1 Virus-like ParticlesCancer Epidemiology, Biomarkers & Prevention, 19
D. Dean (2013)
Cell-Specific Targeting Strategies for Electroporation-Mediated Gene Delivery in Cells and AnimalsThe Journal of Membrane Biology, 246
T. Chuang, Shan-Chih Lee, K. Liao, Y. Hsiao, C. Lo, B. Chiang, Xi-Zhang Lin, M. Tao, R. Chu (2009)
Electroporation‐mediated IL‐12 gene therapy in a transplantable canine cancer modelInternational Journal of Cancer, 125
Maja Ĉemazˆr, T. Jarm, D. Miklavčič, A. Lebar, A. Ihan, N. Kopitar, G. Serša (1998)
Effect of Electric-Field Intensity on Electropermeabilization and Electrosensitmty of Various Tumor-Cell Lines In VitroElectro- and Magnetobiology, 17
N. Tozon, Darja Pavlin, G. Serša, Tanja Dolinšek, M. Čemažar (2014)
Electrochemotherapy with intravenous bleomycin injection: an observational study in superficial squamous cell carcinoma in catsJournal of Feline Medicine and Surgery, 16
W. Zhou, Z. Xiong, Y. Liu, C. Yao, Chengxiang Li (2012)
Low voltage irreversible electroporation induced apoptosis in HeLa cells.Journal of cancer research and therapeutics, 8 1
Elisabeth Ferreira, Esther Potier, D. Logeart-Avramoglou, S. Salomskaite-Davalgiene, S. Salomskaite-Davalgiene, Lluis Mir, Hervé Petite (2008)
Optimization of a gene electrotransfer method for mesenchymal stem cell transfectionGene Therapy, 15
A. Liew, F. André, Léa Lesueur, M. Ménorval, T. O’Brien, L. Mir (2013)
Robust, efficient, and practical electrogene transfer method for human mesenchymal stem cells using square electric pulses.Human gene therapy methods, 24 5
K. Livak, Thomas Schmittgen (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods, 25 4
R Solensky (2003)
Hypersensitivity reactions to beta-lactam antibioticsClin Rev Allergy Immunol, 24
A gene electrotransfer (GET) of interleukin 12 (IL-12) had already given good results when treating tumors in human and veterinary clinical trials. So far, plasmids used in veterinary clinical studies encoded a human or a feline IL-12 and an ampicillin resistance gene, which is not recommended by the regulatory agencies to be used in clinical trials. Therefore, the aim of the current study was to construct the plasmid encoding a canine IL-12 with kanamycin antibiotic resistance gene that could be used in veterinary clinical oncology. The validation of the newly constructed plasmid was carried out on canine malignant melanoma cells, which have not been used in GET studies so far, and on human malignant melanoma cells. Canine and human malignant melanoma cell lines were transfected with plasmid encoding enhanced green fluorescence protein at different pulse parameter conditions to determine the transfection efficiency and cell survival. The IL-12 expression of the most suitable conditions for GET of the plasmid encoding canine IL-12 was determined at mRNA level by the qRT-PCR and at protein level with the ELISpot assay. The obtained results showed that the newly constructed plasmid encoding canine IL-12 had similar or even higher expression capacity than the plasmid encoding human IL-12. Therefore, it represents a promising therapeutic plasmid for further IL-12 gene therapy in clinical studies for spontaneous canine tumors. Additionally, it also meets the main regulatory agencies’ (FDA and EMA) criteria.
The Journal of Membrane Biology – Springer Journals
Published: Apr 4, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.